This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Photodynamic Therapy of Actinic Keratoses With Alacare®

This study has been completed.
Information provided by (Responsible Party):
photonamic GmbH & Co. KG Identifier:
First received: April 3, 2012
Last updated: September 26, 2016
Last verified: September 2016
This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.

Actinic Keratosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Non-interventional Observational Study on Photodynamic Therapy of Actinic Keratoses With Alacare®

Resource links provided by NLM:

Further study details as provided by photonamic GmbH & Co. KG:

Primary Outcome Measures:
  • Number of SCCs in areas treated with Alacare®-PDT [ Time Frame: Two years after Alacare®-PDT ]

Enrollment: 388
Study Start Date: April 2012
Study Completion Date: September 2016
Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Community sample

Inclusion Criteria:

  • Written informed consent
  • Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01571336

Medizinisches Zentrum Bonn Friedensplatz
Bonn, Germany, 53111
Hautarztpraxis Prof. Kurzen
Freising, Germany, 85354
Hautärztliche Gemeinschaftspraxis Dr. med. Peter Dworzak Dr. med. Peter Radny
Friedrichshafen, Germany, 88045
Gemeinschaftspraxis Dres.Ina Röhrig-Petering und Holger Petering
Hildesheim, Germany, 31134
Dermatologische Gemeinschaftspraxis Prof. Dr. J. Gille & Dr. K. Spieth-Gille
Königstein im Taunus, Germany, 61462
Mönchengladbach, Germany, 41061
Facharzt für Haut- und Geschlechtskrankheiten
Radolfzell, Germany, 78315
Praxis Prof. Dr. Thomas Dirschka
Wuppertal, Germany, 42275
Sponsors and Collaborators
photonamic GmbH & Co. KG
Study Chair: Peter Radny, MD Dermatological group practice, Charlottenstraße 12, D-88045 Friedrichshafen, Germany
  More Information

Responsible Party: photonamic GmbH & Co. KG Identifier: NCT01571336     History of Changes
Other Study ID Numbers: NIS 01
Study First Received: April 3, 2012
Last Updated: September 26, 2016

Additional relevant MeSH terms:
Keratosis, Actinic
Skin Diseases
Precancerous Conditions
Neoplasms processed this record on September 25, 2017